Our findings suggest that TSD+ CSCs, a subpopulation of EpCAM+/ABCG2+ CSCs, might engage in a form of self-sacrifice to protect the R-CSC, a pool of dormant CSC population capable of reawakening upon encountering future cisplatin-induced stress and resuming tumor growth. The gene discussed is HEXA; the disease is neoplasm.